#1 Clinical Trials Search in Europe

Fluconazole

This article explores the use of fluconazole, an antifungal medication, in various clinical trials. These studies investigate the drug’s efficacy, safety, bioavailability, and pharmacokinetics in different patient populations and conditions. The trials cover a range of topics, including treatment of fungal infections, prophylaxis, and comparisons between different formulations of fluconazole.

Table of Contents

What is Fluconazole?

Fluconazole is an antifungal medication used to treat various fungal infections. It belongs to a class of drugs called azole antifungals. Fluconazole is also known by the brand name Diflucan[1]. This medication works by stopping the growth of certain types of fungi that can cause infections in the body[2].

What Conditions Does Fluconazole Treat?

Fluconazole is used to treat a variety of fungal infections, including:

  • Candidiasis: This is a common fungal infection caused by Candida species, particularly Candida albicans. It can affect various parts of the body, including the mouth (oral thrush), throat, and genital area[3].
  • Cryptococcal infections: These are serious fungal infections that can affect the brain and lungs, especially in people with weakened immune systems[4].
  • Prophylaxis (prevention) of fungal infections: Fluconazole is sometimes used to prevent fungal infections in people at high risk, such as those undergoing certain medical procedures or with weakened immune systems[5].

How Does Fluconazole Work?

Fluconazole works by inhibiting an enzyme called 14-alpha-demethylase, which is involved in the production of ergosterol, an essential component of fungal cell membranes. By disrupting the formation of ergosterol, fluconazole weakens the fungal cell membrane, leading to cell death and preventing the growth and spread of the fungal infection[6].

Dosage Forms and Administration

Fluconazole is available in various forms and dosages, including:

  • Oral tablets: Commonly available in strengths of 50 mg, 100 mg, 150 mg, and 200 mg[2].
  • Oral suspension: Liquid form for those who have difficulty swallowing tablets.
  • Intravenous (IV) solution: Used in hospital settings for severe infections[7].

The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient’s age, weight, and overall health. For example:

  • For oropharyngeal candidiasis (thrush), a common dosage is 100 mg once daily for 7-14 days[3].
  • For prevention of fungal infections in certain high-risk patients, doses may range from 50-400 mg daily[5].
  • In some cases of severe infections, higher doses up to 800-1200 mg daily may be used[4].

Efficacy Studies

Several clinical trials have been conducted to evaluate the effectiveness of fluconazole in treating various fungal infections:

  • A study compared the efficacy of a single dose of fluconazole (750 mg) to a two-week course (150 mg daily) for treating oropharyngeal candidiasis in HIV-infected individuals. The results suggested that both regimens may be equally effective[3].
  • Another trial investigated the use of fluconazole in combination with flucytosine for treating early cryptococcal infection in HIV-infected individuals with advanced immunosuppression. This study aimed to determine if the combination therapy was safe and potentially more effective than fluconazole alone[4].

Safety and Side Effects

Fluconazole is generally well-tolerated, but like all medications, it can cause side effects. Common side effects may include:

  • Nausea
  • Headache
  • Stomach pain
  • Diarrhea
  • Dizziness
  • Changes in taste

More serious side effects, although rare, can include liver problems, severe skin reactions, and heart rhythm changes. It’s important to report any unusual symptoms to your healthcare provider[5].

Use in Special Populations

Fluconazole use requires special consideration in certain populations:

  • Children: Dosing is often based on the child’s weight. A study investigated the use of fluconazole in children supported by extracorporeal membrane oxygenation (ECMO), a form of life support, to determine appropriate dosing[7].
  • Pregnant women: Fluconazole should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
  • Elderly patients: Dose adjustments may be necessary based on kidney function.
  • Patients with liver or kidney problems: Dose adjustments may be required, and close monitoring is necessary.

Drug Interactions

Fluconazole can interact with various medications, potentially affecting their effectiveness or increasing the risk of side effects. Some notable interactions include:

  • Warfarin (a blood thinner): Fluconazole may increase the effect of warfarin, increasing the risk of bleeding.
  • Certain diabetes medications: Fluconazole may enhance their blood sugar-lowering effects.
  • Some anticonvulsants (seizure medications): Fluconazole may affect their levels in the blood.

It’s crucial to inform your healthcare provider about all medications, supplements, and herbal products you’re taking before starting fluconazole treatment[6].

Aspect Details
Study Types Bioavailability, efficacy, safety, pharmacokinetics/pharmacodynamics
Patient Populations Adults, children, infants, HIV-infected individuals, patients on ECMO
Conditions Studied Oropharyngeal candidiasis, cryptococcal infections, deep mycosis, fungal prophylaxis
Dosage Forms Oral tablets, capsules
Dosing Regimens Single high dose, daily doses for 1-2 weeks, weekly doses
Primary Outcomes Clinical efficacy, mycological eradication, pharmacokinetic parameters, safety assessments
Comparators Generic vs. brand-name formulations, different dosing regimens

FAQ

  • What is fluconazole used for in clinical trials? Fluconazole is used in clinical trials to treat various fungal infections, including oropharyngeal candidiasis, cryptococcal infections, and deep mycosis. It is also studied for prophylactic use in certain high-risk populations, such as HIV-infected individuals and patients undergoing hematopoietic stem cell transplantation.
  • How is fluconazole administered in these trials? Fluconazole is typically administered orally in tablet or capsule form. The dosage and duration vary depending on the specific trial and condition being treated. For example, some studies use a single high dose (e.g., 750mg), while others use daily doses (e.g., 150mg or 200mg) for up to two weeks.
  • What are some of the primary outcomes measured in fluconazole trials? Primary outcomes often include clinical efficacy (e.g., cure rates), mycological eradication rates, pharmacokinetic parameters such as maximum plasma concentration (Cmax) and area under the curve (AUC), and safety assessments including adverse events and treatment-related side effects.
  • Are there any special considerations for fluconazole use in certain populations? Yes, several trials focus on specific populations such as infants, children on extracorporeal membrane oxygenation (ECMO), and HIV-infected individuals. These studies aim to determine appropriate dosing, safety, and efficacy in these particular groups, as drug metabolism and response may differ from the general adult population.
  • What is bioequivalence, and why is it studied for fluconazole? Bioequivalence refers to the comparison of different formulations or brands of a drug to ensure they have similar bioavailability and therapeutic effects. Bioequivalence studies for fluconazole compare generic versions to brand-name products (e.g., Diflucan) to ensure that generic alternatives are safe and effective substitutes for the original medication.

Ongoing Clinical Trials on Fluconazole

  • Study on the Effectiveness of Albaconazole and Fluconazole for Treating Acute Vaginal Yeast Infections in Women

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Poland Spain

Glossary

  • Bioavailability: The extent and rate at which a drug is absorbed into the bloodstream and becomes available at the site of action in the body.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Pharmacodynamics (PD): The study of the biochemical and physiological effects of drugs on the body and the mechanisms of their actions.
  • Area Under the Curve (AUC): A measure of the total exposure to a drug over time, used to assess the extent of drug absorption.
  • Maximum Plasma Concentration (Cmax): The highest concentration of a drug in the blood plasma after administration.
  • Oropharyngeal Candidiasis: A fungal infection of the mouth and throat caused by Candida species, common in immunocompromised individuals.
  • Cryptococcal Infection: A fungal infection caused by Cryptococcus species, which can affect various parts of the body, particularly in immunocompromised patients.
  • Extracorporeal Membrane Oxygenation (ECMO): A life support technique that provides both cardiac and respiratory support to patients whose heart and lungs are unable to function adequately.
  • Prophylaxis: Preventive treatment to stop a disease from occurring, often used in high-risk populations.
  • Bioequivalence: The property of two drug products having the same bioavailability and producing the same therapeutic effect when administered in the same dose.

References

  1. https://clinicaltrials.gov/study/NCT03621072
  2. https://clinicaltrials.gov/study/NCT01511757
  3. https://clinicaltrials.gov/study/NCT00553137
  4. https://clinicaltrials.gov/study/NCT01562132
  5. https://clinicaltrials.gov/study/NCT01680458
  6. https://clinicaltrials.gov/study/NCT04201054
  7. https://clinicaltrials.gov/study/NCT01169402